Annual Operating Expenses
$278.63 M
+$13.61 M+5.14%
December 1, 2024
Summary
- As of March 12, 2025, VCYT annual total operating expenses is $278.63 million, with the most recent change of +$13.61 million (+5.14%) on December 1, 2024.
- During the last 3 years, VCYT annual operating expenses has risen by +$53.15 million (+23.57%).
- VCYT annual operating expenses is now at all-time high.
Performance
VCYT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$71.83 M
+$5.49 M+8.27%
December 31, 2024
Summary
- As of March 12, 2025, VCYT quarterly total operating expenses is $71.83 million, with the most recent change of +$5.49 million (+8.27%) on December 31, 2024.
- Over the past year, VCYT quarterly operating expenses has stayed the same.
- VCYT quarterly operating expenses is now -16.70% below its all-time high of $86.23 million, reached on December 31, 2023.
Performance
VCYT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
VCYT Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.1% | 0.0% |
| 3 y3 years | +23.6% | +29.0% |
| 5 y5 years | +181.5% | +158.3% |
VCYT Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +23.6% | -16.7% | +33.1% |
| 5 y | 5-year | at high | +181.5% | -16.7% | +198.0% |
| alltime | all time | at high | +1759.3% | -16.7% | +1062.4% |
Veracyte Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $71.83 M(+8.3%) |
| Dec 2024 | $278.63 M(+5.1%) | - |
| Sep 2024 | - | $66.34 M(-9.1%) |
| Jun 2024 | - | $72.95 M(+5.7%) |
| Mar 2024 | - | $69.04 M(-19.9%) |
| Dec 2023 | $265.02 M(+15.1%) | $86.23 M(+59.8%) |
| Sep 2023 | - | $53.97 M(-17.4%) |
| Jun 2023 | - | $65.35 M(+1.7%) |
| Mar 2023 | - | $64.27 M(+8.5%) |
| Dec 2022 | $230.29 M(+2.1%) | $59.25 M(+1.6%) |
| Sep 2022 | - | $58.30 M(+1.2%) |
| Jun 2022 | - | $57.63 M(-1.4%) |
| Mar 2022 | - | $58.43 M(+4.9%) |
| Dec 2021 | $225.48 M(+102.4%) | $55.67 M(+1.2%) |
| Sep 2021 | - | $54.99 M(+21.9%) |
| Jun 2021 | - | $45.11 M(-35.3%) |
| Mar 2021 | - | $69.72 M(+121.9%) |
| Dec 2020 | $111.42 M(+12.6%) | $31.42 M(+26.6%) |
| Sep 2020 | - | $24.82 M(+3.0%) |
| Jun 2020 | - | $24.10 M(-22.5%) |
| Mar 2020 | - | $31.08 M(+11.8%) |
| Dec 2019 | $98.97 M(+21.9%) | $27.81 M(+17.7%) |
| Sep 2019 | - | $23.62 M(-3.4%) |
| Jun 2019 | - | $24.46 M(+6.0%) |
| Mar 2019 | - | $23.08 M(+14.8%) |
| Dec 2018 | $81.16 M | $20.10 M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $19.51 M(-4.5%) |
| Jun 2018 | - | $20.42 M(-3.3%) |
| Mar 2018 | - | $21.13 M(+18.2%) |
| Dec 2017 | $70.30 M(+2.7%) | $17.87 M(+6.9%) |
| Sep 2017 | - | $16.72 M(-7.4%) |
| Jun 2017 | - | $18.05 M(+2.3%) |
| Mar 2017 | - | $17.65 M(+14.5%) |
| Dec 2016 | $68.43 M(+11.3%) | $15.41 M(-10.0%) |
| Sep 2016 | - | $17.12 M(-9.3%) |
| Jun 2016 | - | $18.87 M(+10.8%) |
| Mar 2016 | - | $17.02 M(+7.6%) |
| Dec 2015 | $61.47 M(+21.5%) | $15.82 M(+1.4%) |
| Sep 2015 | - | $15.61 M(-1.5%) |
| Jun 2015 | - | $15.84 M(+11.5%) |
| Mar 2015 | - | $14.21 M(-7.7%) |
| Dec 2014 | $50.59 M(+55.9%) | $15.39 M(+14.2%) |
| Sep 2014 | - | $13.48 M(+19.6%) |
| Jun 2014 | - | $11.27 M(+7.9%) |
| Mar 2014 | - | $10.44 M(+14.4%) |
| Dec 2013 | $32.45 M(+41.3%) | $9.13 M(+6.6%) |
| Sep 2013 | - | $8.56 M(+18.0%) |
| Jun 2013 | - | $7.25 M(-3.3%) |
| Mar 2013 | - | $7.50 M(+7.6%) |
| Dec 2012 | $22.97 M(+53.3%) | $6.97 M(+12.8%) |
| Sep 2012 | - | $6.18 M |
| Dec 2011 | $14.99 M | - |
FAQ
- What is Veracyte annual total operating expenses?
- What is the all time high annual operating expenses for Veracyte?
- What is Veracyte annual operating expenses year-on-year change?
- What is Veracyte quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Veracyte?
- What is Veracyte quarterly operating expenses year-on-year change?
What is Veracyte annual total operating expenses?
The current annual operating expenses of VCYT is $278.63 M
What is the all time high annual operating expenses for Veracyte?
Veracyte all-time high annual total operating expenses is $278.63 M
What is Veracyte annual operating expenses year-on-year change?
Over the past year, VCYT annual total operating expenses has changed by +$13.61 M (+5.14%)
What is Veracyte quarterly total operating expenses?
The current quarterly operating expenses of VCYT is $71.83 M
What is the all time high quarterly operating expenses for Veracyte?
Veracyte all-time high quarterly total operating expenses is $86.23 M
What is Veracyte quarterly operating expenses year-on-year change?
Over the past year, VCYT quarterly total operating expenses has changed by $0.00 (0.00%)